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Abstract
Large-scale genome-wide association results are typically obtained from a fixed-effects
meta-analysis of GWAS summary statistics from multiple studies spanning different regions
and/or time periods. This approach averages the estimated effects of genetic variants
across studies. In case genetic effects are heterogeneous across studies, the statistical
power of a GWAS and the predictive accuracy of polygenic scores are attenuated, contribut-
ing to the so-called ‘missing heritability’. Here, we describe the online Meta-GWAS Accuracy
and Power (MetaGAP) calculator (available at www.devlaming.eu) which quantifies this
attenuation based on a novel multi-study framework. By means of simulation studies, we
show that under a wide range of genetic architectures, the statistical power and predictive
accuracy provided by this calculator are accurate. We compare the predictions from the
MetaGAP calculator with actual results obtained in the GWAS literature. Specifically, we
use genomic-relatedness-matrix restricted maximum likelihood to estimate the SNP herita-
bility and cross-study genetic correlation of height, BMI, years of education, and self-rated
health in three large samples. These estimates are used as input parameters for the Meta-
GAP calculator. Results from the calculator suggest that cross-study heterogeneity has led
to attenuation of statistical power and predictive accuracy in recent large-scale GWAS
efforts on these traits (e.g., for years of education, we estimate a relative loss of 51–62% in
the number of genome-wide significant loci and a relative loss in polygenic score R2 of
36–38%). Hence, cross-study heterogeneity contributes to the missing heritability.
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Author Summary
Large-scale genome-wide association studies are uncovering the genetic architecture of
traits which are affected by many genetic variants. In such efforts, one typically meta-
analyzes association results from multiple studies spanning different regions and/or time
periods. Results from such efforts do not yet capture a large share of the heritability. The
origins of this so-called ‘missing heritability’ have been strongly debated. One factor exac-
erbating the missing heritability is heterogeneity in the effects of genetic variants across
studies. The effect of this type of heterogeneity on statistical power to detect associated
genetic variants and the accuracy of polygenic predictions is poorly understood. In the
current study, we derive the precise effects of heterogeneity in genetic effects across stud-
ies on both the statistical power to detect associated genetic variants as well as the accuracy
of polygenic predictions. We present an online calculator, available at www.devlaming.eu,
which accounts for these effects. By means of this calculator, we show that imperfect
genetic correlations between studies substantially decrease statistical power and predictive
accuracy and, thereby, contribute to the missing heritability. The MetaGAP calculator
helps researchers to gauge how sensitive their results will be to heterogeneity in genetic
effects across studies. If strong heterogeneity is expected, random-effects meta-analysis
methods should be used instead of fixed-effects methods.
Introduction
Large-scale GWAS efforts are rapidly elucidating the genetic architecture of polygenic traits,
including anthropometrics [1, 2] and diseases [3–5], as well as behavioral and psychological
outcomes [6–8]. These efforts have led to new biological insights, therapeutic targets, and poly-
genic scores (PGS), and help to understand the complex interplay between genes and environ-
ments in shaping individual outcomes [7, 9, 10]. However, GWAS results do not yet account
for a large part of the estimated heritability [1, 2, 7, 8]. This dissonance, which is referred to as
the ‘missing heritability’, has received broad attention [11–17].
Differences across strata (e.g., studies and populations), in genetic effects, phenotype mea-
surement, and phenotype accuracy, lead to loss of signal [18–20]. Hence, such forms of hetero-
geneity attenuate the statistical power of a GWAS [17, 18, 21, 22] and the predictive accuracy
of a PGS in a hold-out sample [23], and, thereby, contribute to the missing heritability. Since
large-scale GWAS results are typically obtained from a meta-analysis of GWAS results from
many different studies, we focus on the attenuation resulting from heterogeneity at the level of
studies included in such a meta-analysis. Given the importance of discovering trait-affecting
variants and obtaining accurate polygenic predictions, it is vital to understand to which extent
cross-study heterogeneity attenuates the statistical power and predictive accuracy of GWAS
efforts. By considering cross-study differences in genetic effects and heritability, we can quan-
tify this attenuation.
Despite empirical evidence of transethnic genetic heterogeneity in diseases [24] and the fact
that cross-study heterogeneity has been found to decrease the chances of a study to yield mean-
ingful results [22, 25], a theoretical multi-study framework that quantifies the effect of cross-
study heterogeneity on statistical power and predictive accuracy is still absent. We bridge this
gap by developing a Meta-GWAS Accuracy and Power (MetaGAP) calculator (available at
www.devlaming.eu) that accounts for the cross-study genetic correlation (CGR). This calcula-
tor infers the statistical power to detect associated SNPs and the predictive accuracy of the
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PGS in a meta-analysis of GWAS results from genetically and phenotypically heterogeneous
studies, and quantifies the loss in power and predictive accuracy incurred by this cross-
study heterogeneity. Using simulations, we show that the MetaGAP calculator is accurate
under a wide range of genetic architectures, even when the assumptions of the calculator are
violated.
Although meta-analysis methods accounting for heterogeneity exist [26–31], large-scale
GWAS results are typically still obtained from fixed-effects meta-analysis methods [32, 33]
such as implemented in METAL [34]. Therefore, the MetaGAP calculator assumes the use of a
fixed-effects meta-analysis method. Thus, the calculator will help researchers to assess the mer-
its of an intended fixed-effects meta-analysis of GWAS results and to gauge whether it is more
appropriate to apply a meta-analysis method that accounts for heterogeneity.
In an empirical application, we use genomic-relatedness-matrix restricted maximum likeli-
hood (GREML) to estimate the SNP-based heritability (h2SNP) and CGR of several polygenic
traits across three distinct studies: the Rotterdam Study (RS), the Swedish Twin Registry
(STR), and the Health and Retirement Study (HRS). For self-rated health, years of education,
BMI, and height, we obtain point-estimates of CGR between 0.47 and 0.97. Based on these esti-
mates of h2SNP and CGR, we use the MetaGAP calculator to quantify the expected number of
hits and predictive accuracy of the PGS in recent GWAS efforts for these traits. Our theoretical
predictions align with empirical observations.
For height, under an estimated CGR of 0.97, the expected relative loss in the number of
genome-wide significant hits is 8–9%, whereas, for years of education, under an estimated
CGR of 0.78, we expect a relative loss of 51–62% in the number of hits. Moreover, we find that
the relative loss in PGS R2 is expected to be 6–7% for height and 36–38% for years of education.
Hence, our findings show that cross-study heterogeneity attenuates the statistical power and
PGS accuracy considerably, thus, contributing substantially to the missing heritability, and,
more specifically, to the ‘hiding heritability’ [15–17]—defined as the difference between the
SNP-based heritability estimate [35] and the proportion of phenotypic variation explained by
genetic variants that reach genome-wide significance in a GWAS.
Materials and Methods
Definitions and assumptions
The MetaGAP calculator is based on theoretical expressions for statistical power and PGS
accuracy, derived in S1 Derivations and S2 Derivations. In these expressions, within-study esti-
mates of SNP heritability (e.g., inferred using GCTA [36]) are required input parameters. Esti-
mates of CGR (e.g., inferred as genetic correlations across studies using pairwise bivariate
methods as implemented in GCTA [37] and LD-score regression [38, 39], or as genetic-impact
correlation from summary statistics [24]) also play a central role in those expressions. As we
show in S1 Note, such estimates of CGR are affected by the cross-study overlap in trait-affect-
ing loci as well as the cross-study correlation in the effects of these overlapping loci. In our der-
ivations of statistical power and predictive accuracy, we assume, however, that the set of trait-
affecting loci is the same across all studies and that CGRs are, consequently, shaped solely by
cross-study correlations in the effects. Using simulation studies, discussed in S1 Simulations,
we assess how violations of this assumption affect our results.
In addition, genetic correlations as inferred using GCTA [37] or LD-score regression [39]
effectively estimate the cross-trait and/or cross-study correlation in the effects of standardized
SNPs. This correlation has been referred to as the genetic-impact correlation [24]. The scale of
rare variants is inflated most by standardization (i.e., genotypes are scaled by 1=
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
2f ð1   f Þ
p
,
where f denotes the allele frequency of the SNP of interest). Therefore, the scale of the effects of
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these variants is decreased most by standardization of SNPs (i.e., when standardizing a SNP,
the effect is scaled by
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
2f ð1   f Þ
p
). Hence, the genetic-impact correlation emphasizes the con-
tribution of common variants [24]. If rare alleles tend to have larger effects than common
alleles, as assumed in GCTA [36] and LD-score regression [38], these two opposing forces may
cancel each other out; the effects of rare alleles are then bigger, but also scaled downwards
more strongly by considering standardized SNPs. Alternatively, one can also consider the cor-
relation in the effect of non-standardized SNPs, referred to as the genetic-effect correlation
[24]. This genetic-effect correlation gives rare and common variants equal weight in theory.
However, in case rare alleles have larger effects than common alleles, this genetic-effect corre-
lation, in practice, gives a disproportional weight to rare variants.
A clear definition of genetic correlation can be further complicated by the presence of allele
frequency differences across samples. Whereas GCTA assumes fixed allele frequencies across
the samples included in the analysis [36], there also exist methods which allow for differences
in allele frequencies. Ideally, estimates of cross-study genetic-impact correlation accounting
for allele frequency differences [24] should be used in the MetaGAP calculator as input for
CGR. However, provided the genetic drift is small, whether to account for allele frequency dif-
ferences across samples or not, will—in all likelihood—hardly affect the CGR estimates. There-
fore, under little genetic drift, estimates of CGR obtained by methods ignoring cross-study
differences in allele frequencies (e.g., bivariate GREML [37]), suffice as input for the MetaGAP
calculator.
In line with other work, we define the effective number of SNPs, S, as the number of haplo-
type blocks (i.e., independent chromosome segments) [40], where variation in each block is
tagged by precisely one genotyped SNP. By genotyped SNPs we also mean imputed SNPs.
Hence, in our framework, there are S SNPs contributing to the polygenic score. Due to linkage
disequilibrium (LD) this number is likely to be substantially lower than the total number of
SNPs in the genome [41], and is inferred to lie between as little as 60,000 [15] and as much as
5 million [41].
In terms of trait-affecting variants, we consider a subset of M SNPs from the set of S SNPs.
Each SNP in this subset tags variation in a segment that bears a causal influence on the pheno-
type. We refer to M as the associated number of SNPs. We assume that the M associated SNPs
jointly capture the full SNP-based heritability for the trait of interest and, moreover, that each
associated SNP has the same theoretical R2 with respect to the phenotype. In the simulation
studies, we also assess the impact of violations of this ‘equal-R2’ assumption.
By considering only independent genotyped SNPs that are assumed to fully tag the causal
variants, we can ignore LD among genotyped variants and between the causal variant and the
genotyped variants. Thereby, we can greatly reduce the theoretical and numerical complexity
of the MetaGAP calculator. However, a genotyped tag SNP does not necessarily capture the
full variation of the causal variant present in that independent segment. Nevertheless, the
inputs for SNP heritability used in the MetaGAP calculator are within-study GREML estimates
of heritability, based on the available SNPs. Therefore, if these genotyped SNPs are in imper-
fect LD with the causal variants, this will lead to a downward bias in the SNP-based heritability
estimates [42]. Hence, the imperfect tagging of the causal variants is likely to be absorbed by a
downward bias in the SNP-based heritability estimates.
Power of a GWAS meta-analysis under heterogeneity
The theoretical distribution of the Z statistic, resulting from a meta-analysis of GWAS results
under imperfect CGRs, can be found in S1 Derivations. These expressions allow for differences
in sample size, h2SNP, and CGR across (pairs of) studies. For intuition, we here present the
Hiding Heritability and Cross-Study Genetic Overlap
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specific case of a meta-analysis of results from two studies with CGR ρG, with equal SNP-based
heritability h2SNP, and equal sample sizes (i.e., N in Study 1 and N in Study 2). Under this sce-
nario, we find that under high polygenicity, the Z statistic of an associated SNP k is normally
distributed with mean zero and the following variance:
Var Zkð Þ ¼ E Z
2
k
 
 1þ
h2SNP
M
N 1þ rGð Þ: ð1Þ
We incorporate cross-study genetic heterogeneity by assuming that the data-generating pro-
cess follows a random-effects model, where cross-study correlations in SNP effects shape the
inferred CGRs. When one has random effects, under the null hypothesis a SNP effect follows a
degenerate distribution with all probability mass at zero, whereas under the alternative hypoth-
esis a SNP effect follows a distribution with mean zero and a finite non-zero variance. Bearing
in mind that we can write a meta-analysis Z statistic as a weighted average of true effects across
studies and noise terms, the null hypothesis leads to a Z statistic with a mean equal to zero and
a variance equal to one, whereas the alternative hypothesis does not lead to a non-zero mean
in the Z statistic, but rather to excess variation (i.e., a variance larger than one).
The larger the variance in the Z statistic, the higher the probability of rejecting the null. The
ratio of h2SNP and M can be regarded as the theoretical R
2 of each associated SNP with respect to
the phenotype. Eq 1 reveals that (i) when sample size increases, power increases, (ii) when h2SNP
increases, the R2 per associated SNP increases and therefore power increases, (iii) when the
number of associated SNPs increases, the R2 per associated SNP decreases and therefore power
decreases, (iv) when the CGR is zero the power of the meta-analysis is identical to the power
obtained in each of the two studies when analyzed separately, yielding no strict advantage to
meta-analyzing, and (v) when the CGR is positive one, the additional variance in the Z
statistic—compared to the variance under the null—is twice the additional variance one would
have when analyzing the studies separately, yielding a strong advantage to meta-analyzing.
Notably, our expression for E ½Z2k  bears a great resemblance to expressions for the expected
value of the squared Z statistic when accounting for LD, population stratification, and polyge-
nicity [38, 43, 44]. Consider the scenario where the CGR between two samples of equal size is
positive one. Based of Eq 1, we then have that E Z2k
 
 1þ
h2SNP
M NT for a trait-affecting haplo-
type block, where NT = 2N denotes the total sample size. This expression is equivalent to the
expected squared Z statistic from the linear regression analysis for a trait-affecting variant
reported in Section 4.2 of the Supplementary Note to [44] as well as the first equation in [38]
when assuming that confounding biases and LD are absent.
In order to compute statistical power in a multi-study setting, we first use the generic
expression for the variance of the GWAS Z statistic derived in S1 Derivations to characterize
the distribution of the Z statistic under the alternative hypothesis. Given a genome-wide signif-
icance threshold (denoted by α; usually α = 5  10−8), we use the normal cumulative distribu-
tion function under the alternative hypothesis to quantify the probability of attaining genome-
wide significance for an associated SNP. This probability we refer to as the ‘power per associ-
ated SNP’ (denoted here by β). Given that we use SNPs tagging independent haplotype blocks,
we can calculate the probability of rejecting the null for at least one SNP and the expected
number of hits, true positives, false positives, false negatives, and positive negatives, as func-
tions of α, β, the number of truly associated SNPs (denoted by M), and the number of non-
associated SNPs (denoted by S −M). Letting ‘#’ denote the number of elements in a set, we
Hiding Heritability and Cross-Study Genetic Overlap
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have that
P ½# truepositives  1 ¼ 1   ð1   bÞM;
P ½# hits  1 ¼ 1   ½ð1   bÞMð1   aÞS  M;
E ½# hits ¼ bM þ aðS   MÞ;
E ½# truepositives ¼ bM;
E ½# false positives ¼ aðS   MÞ;
E ½# false negatives ¼ ð1   bÞM; and
E ½# true negatives ¼ ð1   aÞðS   MÞ:
R2 of a polygenic score under heterogeneity
In S2 Derivations we derive a generic expression for the theoretical R2 of a PGS in a hold-out
sample, with SNP weights based on a meta-analysis of GWAS results under imperfect CGRs.
We consider a PGS that includes all the SNPs that tag independent haplotype blocks (i.e., there
is no SNP selection).
For intuition, we here present an approximation for prediction in a hold-out sample, with
SNP weights based on a GWAS in a single discovery study with sample size N, where both
studies have SNP heritability h2SNP, and with CGR ρG, between the studies. Under high polyge-
nicity, the R2 of the PGS in the hold-out sample is then given by the following expression:
R2  h2SNPr
2
G
h2SNP
S
N þ h2SNP
: ð2Þ
In case the CGR is one, and we consider the R2 between the PGS and the genetic value (i.e., the
genetic component of the phenotype) instead of the phenotype itself, the first two terms in Eq
2 disappear, yielding an expression equivalent to the first equation in [40]. Assuming a CGR of
one and that all SNPs are associated, Eq 2 is equivalent to the expression in [23] for the R2
between the PGS and the phenotype in the hold-out sample.
From Eq 2, we deduce that (i) as the effective number of SNPs S increases, the R2 of the
PGS deteriorates (since every SNP-effect estimate contains noise, owing to imperfect infer-
ences in finite samples), (ii) given the effective number of SNPs, under a polygenic architec-
ture, the precise fraction of effective SNPs that is associated does not affect the R2, (iii) R2 is
quadratically proportional to ρG, implying a strong sensitivity to CGR, and (iv) as the sample
size of the discovery study grows, the upper limit of the R2 is given by h2SNPr
2
G, implying that the
full SNP heritability in the hold-out sample cannot be entirely captured as long as CGR is
imperfect.
Online power and R2 calculator
An online version of the MetaGAP calculator can be found at www.devlaming.eu. This calcula-
tor computes the theoretical power per trait-affecting haplotype block, the power to detect at
least one of these blocks, and the expected number of (a) independent hits, (b) true positives,
(c) false positives, (d) false negatives, and (e) true negatives, for a meta-analysis of GWAS
results from C studies. In addition, it provides the expected R2 of a PGS for a hold-out sample,
including all GWAS SNPs, with SNP weights based on the meta-analysis of the GWAS results
from C studies. Calculations are based on the generic expressions for GWAS power derived in
S1 Derivations and PGS R2 derived in S2 Derivations.
Hiding Heritability and Cross-Study Genetic Overlap
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The calculator assumes a quantitative trait. Users need to specify either the average
sample size per study or the sample size of each study separately. In addition, users need to
specify either the average within-study SNP heritability or the SNP heritability per study. The
SNP heritability in the hold-out sample also needs to be provided. Users are required to enter
the effective number of causal SNPs and the effective number of SNPs in total. The calculator
assumes a fixed CGR between all pairs of studies included in the meta-analysis and a fixed
CGR between the hold-out sample and each study in the meta-analysis. Hence, one needs to
specify two CGR values: one for the CGR within the set of meta-analysis studies and one to
specify the genetic overlap between the hold-out sample and the meta-analysis studies.
Finally, a more general version of the MetaGAP calculator is provided in the form of
MATLAB code (www.mathworks.com), also available at www.devlaming.eu. This code can be
used in case one desires to specify a more versatile genetic-correlation matrix, where the CGR
can differ between all pairs of studies. Therefore, this implementation requires the user to spec-
ify a full (C+1)-by-(C+1) correlation matrix. Calculations in this code are also fully in line with
the generic expressions in S1 Derivations and S2 Derivations.
Assessing validity of theoretical power and R2
We simulate data for a wide range of genetic architectures in order to assess the validity of our
theoretical framework. As we show in S1 Simulations, the theoretical expressions we derive for
power and R2 are accurate, even for data generating processes substantially different from the
process we assume in our derivations. Our strongest assumptions are that all truly associated
SNPs have equal R2 with respect to the phenotype, regardless of allele frequency, and that
genome-wide CGRs are shaped solely by the cross-study correlations in the effects of causal
SNPs. When we simulate data where the former assumption fails and where—in addition—
allele frequencies are non-uniformly distributed and different across studies, the root-mean-
square prediction error of statistical power lies below 3% and that of PGS R2 below 2%. More-
over, when we simulate data where the CGR is shaped by both non-overlapping causal loci
across studies and the correlation of the effects of the overlapping loci, the RMSE is less than
2% for both statistical power and PGS R2.
Estimating SNP heritability and CGR
Using 1000-Genomes imputed data from the RS, STR, and HRS, we estimate SNP-based heri-
tability and CGR respectively by means of univariate and bivariate GREML [36, 37] as imple-
mented in GCTA [36]. In our analyses we consider the subset of HapMap3 SNPs available
in the 1000-Genomes imputed data. In S1 Data we report details on the genotype and pheno-
type data, as well as our quality control (QC) procedure. After QC we have a dataset,
consisting of 1 million SNPs and 20,000 individuals, from which we infer h2SNP and CGR.
In S1 Estimation we provide details on the specifications of the models used for GREML
estimation.
Ethics statement
Written informed consent was provided by all participants and the research project was
approved by the Ethics Committee of Erasmus Medical Center (MEC 02.1015), the Ethics
Committee of Stockholm (2007-644-31, 2011-463-32, 2012/270-31/2), the ERIM Institutional
Review Board (2014-04), and dbGaP (#3544, #5752, #5082, #5285).
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Results
Determinants of GWAS power and PGS R2
Using the MetaGAP calculator, we assessed the theoretical power of a meta-analysis of GWAS
results from genetically heterogeneous studies and the theoretical R2 of the resulting PGS in a
hold-out sample, for various numbers of studies and sample sizes, and different values of CGR
and h2SNP.
Sample size and CGR. Fig 1 shows contour plots for the power per truly associated SNP
and R2, for a setting with 50 studies, for a trait with h2SNP ¼ 50%, for various combinations of
total sample size and CGR. Increasing total sample size enhances both power and R2. When
the CGR is perfect, power and R2 (relative to h2SNP) have a near-identical response to sample
size. This similarity in response gets distorted when the CGR decreases. For instance, in the
scenario of 100k SNPs of which a subset of 1k SNPs is causal with h2SNP ¼ 50%, in a sample of
50 studies with a total sample size of 10 million individuals, a CGR of one yields 94% power
per causal SNP and an R2 of 49%, which is 98% of the SNP heritability, whereas for a CGR of
0.2 the power is still 87% per SNP, while the R2 of the PGS is 8.5%, which is only 17% of h2SNP.
Thus, R2 is far more sensitive to an imperfect CGR than the meta-analytic power is. This find-
ing is also supported by the approximations of power in Eq 1 and of PGS R2 in Eq 2; these
expressions show that, for two discovery studies, the CGR has a linear effect on the variance of
the meta-analysis Z statistic, whereas, for one discovery and one hold-out sample, the PGS R2
is quadratically proportional to the CGR.
SNP heritability and CGR. Fig 2 shows contour plots for the power per truly associated
SNP and R2 for a setting with 50 studies, with a total sample size of 250,000 individuals, for 1k
causal SNPs and 100k SNPs in total, for various combinations of h2SNP and CGR. The figure
shows a symmetric response of both power and R2 to CGR and h2SNP. For instance, when
h2SNP ¼ 25% and CGR = 0.5 across all studies, the power is expected to be around 34% and the
R2 3.0%. When these numbers are interchanged (i.e., h2SNP ¼ 50% and CGR = 0.25), similarly,
the power is expected to be 35% and the R2 2.9%. Hence, in terms of both R2 and power, a low
heritability can be compensated by a high CGR (e.g., by means of homogeneous measures
across studies) and a low CGR can be compensated by high heritability. When either CGR or
heritability is equal to zero, both power and R2 are decimated in the multi-study setting. How-
ever, when both are moderately low but still substantially greater than zero, neither power nor
R2 are completely diminished.
Number of studies and CGR. Fig 3 shows contour plots for the power per truly associated
SNP and R2 for a trait with h2SNP ¼ 50%, 1k causal SNPs, 100k SNPs in total, and a fixed total
sample size of 250,000 individuals. In this figure, various combinations of the CGR and the
number of studies are considered. Logically, when there is just one study for discovery, CGR
does not affect power. However, even for two studies, the effect of CGR on power is quite pro-
nounced. For instance, when CGR is a half, the power per causal SNP is 63% for one study,
58% for two studies, 51% for ten studies, and 50% for 100 studies. Thus, when the number of
studies is low, increasing the number of studies makes the effect of CGR on power more pro-
nounced rapidly. When the number of studies is large, further increases in the number of stud-
ies hardly make the effect of CGR on power more pronounced.
For a given number of studies, we observed that the effect CGR has on R2 is stronger than
the effect it has on power. This observation is in line with the approximated theoretical R2 in
Eq 2, indicating that R2 is quadratically proportional to CGR. However, an interesting observa-
tion is that this quadratic relation lessens as the number of studies grows large, despite the
total sample size being fixed. For instance, at a CGR of a half, the R2 in the hold-out sample is
Hiding Heritability and Cross-Study Genetic Overlap
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Fig 1. Theoretical predictions of power per causal SNP (upper panel) and out-of-sample R2 of the PGS
(lower panel), for total sample size (x-axis) and cross-study genetic correlation (y-axis). Factor levels:
50 studies, 100k independent SNPs, and h2SNP ¼ 50% arising from a subset of 1k independent SNPs.
doi:10.1371/journal.pgen.1006495.g001
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Fig 2. Theoretical predictions of power per causal SNP (upper panel) and out-of-sample R2 of the PGS
(lower panel), for a trait that across studies has SNP heritability (x-axis) and cross-study genetic
correlation (y-axis). Factor levels: 50 studies, sample size 5,000 individuals per study, 100k independent
SNPs, and heritability arising from a subset of 1k independent SNPs.
doi:10.1371/journal.pgen.1006495.g002
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Fig 3. Theoretical predictions of power per causal SNP (upper panel) and out-of-sample R2 of the PGS
(lower panel), for a trait with GWAS results from the number of studies (x-axis) with cross-study
genetic correlation (y-axis). Factor levels: total sample size 250,000 individuals, 100k independent SNPs,
and h2SNP ¼ 50% arising from a subset of 1k independent SNPs.
doi:10.1371/journal.pgen.1006495.g003
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expected to be 6.9% when there is only one discovery study. However, the expected R2 is 8.1%
for two discovery studies, 9.3% for ten discovery studies, and 9.6% for 100 discovery studies. A
likely reason for this pattern is that, in case of one discovery study, the PGS is influenced rela-
tively strongly by the study-specific component of the genetic effects. This idiosyncrasy is not
of relevance for the hold-out sample. As the number of studies increases—even though each
study brings its own idiosyncratic contribution—each study consistently conveys information
about the part of the genetic architecture which is common across the studies. Since the idio-
syncratic contributions from the studies are independent, they tend to average each other out,
whereas the common underlying architecture gets more pronounced as the number of studies
in the discovery increases, even if the total sample size is fixed.
SNP heritability in the hold-out sample. Fig 4 shows a contour plot for the PGS R2 based
on a meta-analysis of 50 studies with a total sample size of 250,000 individuals, with 1k causal
SNPs and 100k SNPs in total, and a CGR of 0.8 between both the discovery studies and the
hold-out sample. In the plot, various combinations of h2SNP in the discovery samples and h
2
SNP in
the hold-out sample are considered. The response of PGS R2 to heritability in the discovery
sample and the hold-out sample is quite symmetric, in the sense that a low h2SNP in the discov-
ery samples and a high h2SNP in the hold-out sample yield a similar R
2 as a high h2SNP in the dis-
covery sample and a low h2SNP in the hold-out sample. However, R
2 is slightly more sensitive to
h2SNP in the hold-out sample than in the discovery samples. For instance, when SNP heritability
in the discovery samples is 50% and 25% in the hold-out sample, the expected R2 is 10%,
whereas in case the SNP heritability is 25% in the discovery samples and 50% in the hold-out
sample, the expected R2 is 13%.
Fig 4. Theoretical predictions of out-of-sample R2 of the PGS, for the SNP heritability in the hold-out
sample (x-axis) and the SNP heritability in the discovery samples (y-axis). Factor levels: 50 studies,
sample size 5,000 individuals per study, cross-study genetic correlation 0.8, 100k independent SNPs, and
heritability arising from a subset of 1k independent SNPs.
doi:10.1371/journal.pgen.1006495.g004
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CGR between sets of studies. Fig 5 shows a contour plot for the power per truly associ-
ated SNP in a setting where there are two sets consisting of 50 studies each. Within each set,
the CGR is equal to one, whereas between sets the CGR is imperfect. Consider, for example, a
scenario where one wants to meta-analyze GWAS results for height from a combination of
two sets of studies; one set of studies consisting primarily of individuals of European ancestry
and one set of studies with mostly individuals of Asian ancestry in it. Now, one would expect
CGRs close to one between studies consisting primarily of individuals of European ancestry
and the same for the CGRs between studies consisting primarily of individuals of Asian ances-
try. However, the CGRs between those two sets of studies may be less than one.
As is shown in S1 Derivations, in case the CGR between the two sets of studies, C1 and C2, is
zero, meta-analyzing the two sets jointly yields power bC1[ C2  maxfbC1 ; bC2g and
bC1[ C2  minfbC1 ; bC2g, where bA denotes the power in set of studies A. In particular, when
bC1 ¼ bC2 we have under a CGR of zero between the sets, that bC1[ C2 ¼ bC1 ¼ bC2 . Since in
Fig 5 we considered two equally-powered sets, the power of a meta-analysis using both sets,
under zero CGR between sets, is identical to the power obtained when meta-analyzing, for
instance, only the first set. However, as CGR between sets increases, so does power. For
instance, when a total sample size of 250,000 individuals is spread across 2 clusters, each cluster
consisting of 50 studies (i.e., sample size of 125,000 individuals per cluster and 2,500 individu-
als per study), under h2SNP ¼ 50% due to 1k causal SNPs, a CGR of one within each cluster, and
CGR of zero between clusters, the power is expected to be 49%, which is identical to the power
of a meta-analysis of either the first or the second cluster. However, if the CGR between clus-
ters is 0.5 instead of zero, the power goes up to 58%. In terms of the expected number of hits,
Fig 5. Theoretical predictions of power per causal SNP, for total sample size (x-axis) and CGR
between two sets of studies (y-axis). Factor levels: 2 sets of 50 studies, CGR equal to 1 within both sets,
100k independent SNPs, and h2SNP ¼ 50% arising from a subset of 1k independent SNPs.
doi:10.1371/journal.pgen.1006495.g005
Hiding Heritability and Cross-Study Genetic Overlap
PLOS Genetics | DOI:10.1371/journal.pgen.1006495 January 17, 2017 13 / 23
this cross-ancestry meta-analysis yields an expected 82 additional hits, compared to a meta-
analysis considering only one ancestry.
Alternatively, one could carry out a meta-analysis in each set of studies and pool the hits
across these sets. However, this would imply more independent tests being carried out, and,
hence, the need for a more stringent genome-wide significance threshold, in order to keep the
false-positive rate fixed. Therefore, this route may yield less statistical power than a meta-
analysis of merely one of the two sets or a joint analysis of both. Ideally, in the scenario where
between-population heterogeneity is likely, one should apply a meta-analysis method that
accounts for the heterogeneity (e.g., [26–31]). By applying such a method, one can consider all
GWAS results from different ancestry groups in one analysis.
Empirical results for SNP-based heritability and CGR
In Table 1 we report univariate GREML estimates of SNP heritability and bivariate GREML
estimates of genetic correlation for traits that attained a pooled sample size of at least 18,000
individuals, which gave us at least 50% power to detect a genetic correlation near one for a trait
that has a SNP heritability of 10% or more [45]. The smallest total sample size is NT = 19,184
for self-rated health. Details per phenotype on sample size, univariate estimates of SNP herita-
bility, and bivariate estimates of genetic correlation, stratified across studies, and cross-study
averages, are provided in S1 Table. Results stratified across sexes are listed in S2 Table.
The univariate estimates of SNP heritability based on the pooled data assume perfect CGRs.
Therefore, such estimates of SNP heritability are downwards biased when based on data from
multiple studies with imperfect CGRs. To circumvent this bias, we estimated SNP heritability
in each study separately, and focused on the sample-size-weighted cross-study average esti-
mate of SNP heritability.
For both height and BMI, we observed genetic correlations close to one across pairs of stud-
ies and between females and males. For years of schooling (EduYears) we found a CGR around
Table 1. GREML estimates of SNP heritability and genetic correlation across studies and sexes.
Phenotype N Estimates SNP heritability1 Estimates genetic correlation1,2
pooled3 study4 sexes5 RS–STR RS–HRS STR–HRS Females–Males
Height 20,458 43.3% (1.8%) *** 44.9% 44.0% 0.976 (0.102) *** 0.954 (0.095) *** 0.967 (0.106) *** 0.981 (0.067) ***
BMI 20,449 20.9% (1.7%) *** 21.9% 22.8% 1.000 (0.269) *** 0.914 (0.172) *** 0.847 (0.246) *** 0.794 (0.122) *** †
EduYears 20,619 16.4% (1.7%) *** 18.2% 18.4% 0.690 (0.233) *** 0.659 (0.224) *** † 1.000 (0.263) *** 0.832 (0.162) ***
CurrCigt 20,686 18.2% (4.0%) *** 19.1% 24.2% 1.000 (0.643) *** 0.611 (0.448) * 1.000 (0.607) *** 0.543 (0.257) *** †
CurrDrinkFreq 20,072 7.0% (2.6%) *** 10.3% 8.3% 1.000 (0.666) *** 0.298 (0.670) -0.056 (0.647) 1.000 (2.068) *
Self-rated health 19,184 10.3% (1.8%) *** 15.7% 9.5% 0.626 (0.439) ** 0.363 (0.223) ** †† 0.447 (0.278) ** 1.000 (0.349) ***
1 Standard errors between parentheses.
2 Significance of deviations from one only tested for genetic correlations.
3 Univariate estimates from pooled data.
4 Sample-size weighted averages of univariate estimates across studies.
5 Sample-size weighted averages of univariate estimates across sexes.
* > 0 at 10% sign.
** > 0 at 5% sign.
*** > 0 at 1% sign.
† < 1 at 10% sign.
†† < 1 at 5% sign.
††† < 1 at 1% sign.
doi:10.1371/journal.pgen.1006495.t001
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0.8 when averaged across pairs of studies. Similarly, the genetic correlation for EduYears in
females and males lies around 0.8. The CGR of self-rated health is substantially below one
across the pairs of studies, whilst the genetic correlation between females and males seems to
lie around one. The reason for this difference in the genetic correlation of self-rated health
between pairs of studies and between females and males may be due to the difference in the
questionnaire across studies, discussed in S1 Data. The questionnaire differences can yield a
low CGR, while not precluding the remaining genetic overlap for this measure across the three
studies, to be highly similar for females and males. For CurrCigt and CurrDrinkFreq, the esti-
mates of CGR and of genetic correlation between females and males are non-informative. For
these two traits the standard errors of the genetic correlations estimates are large, mostly
greater than 0.5. In addition, for CurrDrinkFreq there is strong volatility in the CGR estimate
across pairs of studies.
Attenuation in power and R2 due to imperfect CGR
Considering only the traits for which we obtained accurate estimates of CGR and SNP herita-
bility (i.e., with low standard errors), we used the MetaGAP calculator to predict the number
of hits in a set of discovery samples and the PGS R2 in a hold-out sample, in prominent GWAS
efforts for these traits. Details and notes on the results from existing studies, used as input for
the MetaGAP calculations, can be found S3 Table. Importantly, as reported in S4 Table, for the
traits under consideration here, large-scale GWAS results to date have been obtained using
fixed-effects meta-analyses.
Since we only had accurate estimates for height, BMI, EduYears, and self-rated health, we
focused on these four phenotypes. For these traits, we computed sample-size-weighted average
CGR estimates across the pairs of studies. Table 2 shows the number of hits and PGS R2
reported in the most comprehensive GWAS efforts to date for the traits of interest, together
Table 2. Predicted and observed number of genome-wide-significant hits and PGS R2, for large-scale GWAS efforts to date for height, BMI, Edu-
Years, and self-rated health, assuming 250k effective SNPs (i.e., independent haplotype blocks) of which 20k trait-affecting, using averaged
GREML estimates from Table 1 for setting SNP heritability and CGR. Notes on the sources for the large-scale GWAS efforts are listed in S3 Table.
Phenotype Main studies Architecture Number of hits PGS R2 using all SNPs
Study N C ** h2SNP CGR Study Theory|CGR Attenuation* Study Theory|CGR Attenuation*
<1 =1 <1 =1
Height Wood et al. (2014) [1] 253,288 79 44.9% 0.965 697 647.26 700.24 8% 13.5% 13.2% 14.0% 6%
Allen et al. (2010) [46] 183,727 61 44.9% 0.965 180 292.03 320.77 9% 10.0% 10.5% 11.1% 6%
Weedon et al. (2008)
[47]
13,665 5 44.9% 0.965 7 0.00 0.00 n.a. 2.9% 1.0% 1.1% 7%
BMI Locke et al. (2015) [2] 339,224 125 21.9% 0.917 97 188.52 241.07 22% 6.5% 4.3% 5.0% 14%
Speliotes et al. (2010)
[48]
123,865 46 21.9% 0.917 19 5.48 7.64 28% 2.5% 1.8% 2.1% 15%
Willer et al. (2008) [49] 32,387 15 21.9% 0.917 1 0.01 0.02 65% n.a. 0.5% 0.6% 16%
EduYears Okbay et al. (2016) [7] 405,072 65 18.2% 0.783 162 115.28 235.90 51% n.a. 2.7% 4.1% 36%
Okbay et al. (2016) [7] 293,723 64 18.2% 0.783 74 39.30 88.93 56% 3.9% 2.0% 3.2% 36%
Rietveld et al. (2013)
[50]
101,069 42 18.2% 0.783 1 0.63 1.64 62% 2.5% 0.8% 1.2% 38%
Self-rated
health
Harris et al. (2016) [51] 111,749 1 15.7% 0.468 13 1.35 1.35 0% n.a. 0.2% 1.0% 78%
* Attenuation measures the relatively loss in expected power and R2 due to a CGR in accordance with averaged GREML estimates from Table 1.
** C denotes the number of studies in the meta-analysis.
doi:10.1371/journal.pgen.1006495.t002
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with predictions from the MetaGAP calculator. We tried several values for the number of inde-
pendent haplotype blocks (i.e., 100k, 150k, 200k, 250k) and for the number of trait-associated
blocks (i.e., 10k, 15k, 20k, 25k). Overall, 250k blocks of which 20k trait-affecting yielded theo-
retical predictions in best agreement with the empirical observations; we acknowledge the
potential for some overfitting (i.e., two free parameters set on the basis of 17 data points; 10
data points for the reported number of hits and 7 for PGS R2).
For height—the trait with the lowest standard error in the estimates of h2SNP and CGR—the
predictions of the number of hits and PGS R2 for the two largest GWAS efforts are much in
line with theoretical predictions. For the smaller GWAS of 13,665 individuals [47], our esti-
mates seem slightly conservative; 0 hits expected versus the 7 reported. However, in our frame-
work, we assumed that each causal SNP has the same R2. Provided there are some differences
in R2 between causal SNPs, the first SNPs that are likely to reach genome-wide significance in
relatively small samples, are the ones with a comparatively large R2. This view is supported by
the fact that a PGS based on merely 20 SNPs already explains 2.9% of the variation in height.
Hence, for relatively small samples our theoretical predictions of power and R2 may be some-
what conservative. In addition, the 10k SNPs with the lowest meta-analysis p-values can
explain about 60% of the SNP heritability [1]. If the SNPs tagging the remaining 40% each
have similar predictive power as the SNPs tagging the first 60%, then the number of SNPs
needed to capture the full h2SNP would lie around 10k/0.6 = 17k, which is somewhat lower than
the 20k which yields the most accurate theoretical predictions. However, as indicated before,
the SNPs which appear most prominent in a GWAS are likely to be the ones with a greater
than average predictive power. Therefore, the remaining 40% of h2SNP is likely to be stemming
for SNPs with somewhat lower predictive power. Hence, 20k associated independent SNPs is
not an unreasonable number for height.
The notion of a GWAS first picking up the SNPs with a relatively high R2 is also supported
by the predicted and observed number of hits for the reported self-rated-health GWAS [51];
given a SNP heritability estimate between 10% [51] and 16% (Table 2), according to our theo-
retical predictions, a GWAS in a sample of around 110k individuals is unlikely to yield even a
single genome-wide significant hit. Nevertheless, this GWAS has yielded 13 independent hits.
This finding supports the idea that for various traits, some SNPs with a relatively high R2 are
present. However, there is uncertainty in the number of truly associated loci. More accurate
estimates of this number may improve the accuracy of our theoretical predictions.
For BMI our predictions of PGS R2 were quite in line with empirical results. However, for
the number of hits, our predictions for the largest efforts seemed overly optimistic. We there-
fore suspect that the number of independent SNPs associated with BMI is higher than 20k; a
higher number of associated SNPs would reduce the GWAS power, while preserving PGS R2,
yielding good agreement with empirical observation. Nevertheless, given the limited number
of data points, this strategy of setting the number of causal SNPs would increase the chance of
overfitting.
For EduYears we observed that the reported number of hits is in between the expected
number of hits when the CGR is set to the averaged GREML estimate of 0.783 and when the
CGR is set to one. Given the standard errors in the CGR estimates for EduYears, the CGR
might very well be somewhat greater than 0.783, which would yield a good fit with the reported
number of hits. However, as with the number of truly associated SNPs for BMI, in light of the
risk of overfitting, we can make no strong claims about a slightly higher CGR of EduYears.
Overall, our theoretical predictions of the number of hits and PGS R2 are in moderate
agreement with empirical observations, especially when bearing in mind that we are looking at
a limited number of data points, making chance perturbations from expectation likely. In
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addition, regarding the number of hits, the listed studies are not identical in terms of the pro-
cedure to obtain the independent hits. Therefore, the numbers could have been slightly differ-
ent, had the same pruning procedure been used across all reported studies.
Regarding attenuation, we observed a substantial spread in the predicted number of hits
and PGS R2 when assuming either a CGR equal to one, or a CGR in accordance with empirical
estimates, with traits with lower CGR suffering from stronger attenuation in power and pre-
dictive accuracy. In line with theory, R2 falls approximately quadratically with CGR. For
instance, for self-rated health, the estimated CGR of about 0.5, would yield a PGS that retains
approximately 0.52 = 25% of the R2 it would have had under a CGR of one. Hence the approxi-
mated attenuation is 75%. This approximation is corroborated by the theoretical relative atten-
uation of 78%.
Given our CGR estimates, the theoretical relative loss in PGS R2 is 6% for height, 14% for
BMI, 36% for EduYears, and 78% for self-rated health, when compared to the R2 of PGSs
under perfect CGRs (Table 2). These losses in R2 are unlikely to be reduced by larger sample
sizes and denser genotyping.
Somewhat contrary to expectation, the number of hits seems to respond even more strongly
to CGR than PGS R2. However, since in each study under consideration the average power per
associated SNP is quite small, a small decrease in power per SNP in absolute terms can consti-
tute a substantial decrease in relative terms. For instance, when one has 2% power per truly
associated SNP, an absolute decrease of 1%—leaving 1% power—constitutes a relative decrease
of 50% of power per causal SNP, and thereby a 50% decrease in the expected number of hits.
This strong response shows, for example, in the case of EduYears, where the expected number
of hits drop by about 37% when going from a CGR of one down to a CGR of 0.783.
Discussion
We have shown that imperfect cross-study genetic correlations (CGRs) are likely to contribute
to the gap between the phenotypic variation accounted for by all SNPs jointly and by the lead-
ing GWAS efforts to date. We arrived at this conclusion in five steps. First, we developed a
Meta-GWAS Accuracy and Power (MetaGAP) calculator that accounts for the CGR. This
online calculator relates the statistical power to detect associated SNPs and the R2 of the poly-
genic score (PGS) in a hold-out sample to the number of studies, sample size and SNP herita-
bility per study, and the CGR. The underlying theory shows that there is a quadratic response
of the PGS R2 to CGR. Moreover, we showed that the power per associated SNP is also affected
by CGR.
Second, we used simulations to demonstrate that our theory is robust to several violations
of the assumptions about the underlying data-generating process, regarding the relation
between allele frequency and effect size, the distribution of allele frequencies, and the factors
contributing to CGR. Further research needs to assess whether our theoretical predictions are
also accurate under an even broader set of scenarios (e.g., when studying a binary trait).
Third, we used a sample of unrelated individuals from the Rotterdam Study, the Swedish
Twin Registry, and the Health and Retirement Study, to estimate SNP-based heritability as
well as the CGR for traits such as height and BMI. Although our CGR estimates have consider-
able standard errors, the estimates make it likely that for many polygenic traits the CGR is pos-
itive, albeit smaller than one.
Fourth, based on these empirical estimates of SNP heritability and CGR for height, BMI,
years of education, and self-rated health, we used the MetaGAP calculator to predict the num-
ber of expected hits and the expected PGS R2 for the most prominent studies to date for these
traits. We found that our predictions are in moderate agreement with empirical observations.
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Our theory seems slightly conservative for smaller GWAS samples. For large-scale GWAS
efforts our predictions were in line with the outcomes of these efforts. More accurate estimates
of the number of truly associated loci may further improve the accuracy of our theoretical
predictions.
Fifth, we used our theoretical model to assess statistical power and predictive accuracy for
these GWAS efforts, had the CGR been equal to one for the traits under consideration. Our
estimates of power and predictive accuracy in this scenario indicated a strong decrease in the
PGS R2 and the expected number of hits, due to imperfect CGRs. Though these observations
are in line with expectation for predictive accuracy, for statistical power the effect was larger
than we anticipated. This finding can be explained, however, by the fact that though the abso-
lute decrease in power per SNP is small, the relative decrease is large, since the statistical power
per associated SNP is often low to begin with.
Overall, our study affirms that although PGS accuracy improves substantially with further
increasing sample sizes, in the end PGS R2 will continue to fall short of the full SNP-based heri-
tability. Hence, this study contributes to the understanding of the hiding heritability reported
in the GWAS literature.
Regarding the etiology of imperfect CGRs, the likely reasons are heterogeneous phenotype
measures across studies, gene–environment interactions with underlying environmental fac-
tors differing across studies, and gene–gene interactions where the average effects differ across
studies due to differences in allele frequencies. Our study is not able to disentangle these differ-
ent causes; by estimating the CGR for different traits we merely quantify the joint effect these
three candidates have on the respective traits.
However, in certain situations it may be possible to disentangle the etiology of imperfect
CGRs to some extent. For instance, in case one considers a specific phenotype that is usually
studied by means of a commonly available but relatively heterogeneous and/or noisy measure,
while there also exists a less readily available but more accurate and homogeneous measure. If
one has access to both these measures in several studies, one can compare the CGR estimates
for the more accurate measure and the CGR estimates for the less accurate but more com-
monly available measure. Such a comparison would help to disentangle the contribution of
phenotypic heterogeneity and genetic heterogeneity to the CGR of the more commonly avail-
able measure.
In considering how to properly address imperfect CGRs, it is important to note that having
a small set of large studies, rather than a large set of small studies, does not necessarily abate the
problem of imperfect genetic correlations. Despite the fact that having fewer studies can help to
reduce the effects of heterogeneous phenotype measures, larger studies are more likely to sam-
ple individuals from different environments. If gene–environment interactions do play a role,
strong differences in environment between subsets of individuals in a study can lead to imper-
fect genetic correlations within that study. The attenuation in power and accuracy resulting
from such within-study heterogeneity may be harder to address than cross-study heterogeneity.
Our findings stress the importance of considering the use of more sophisticated meta-anal-
ysis methods that account for cross-study heterogeneity [26–31]. We believe that the online
MetaGAP calculator will prove to be an important tool for assessing whether an intended
fixed-effects meta-analysis of GWAS results from different studies is likely to yield meaningful
outcomes.
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